<DOC>
	<DOC>NCT02380742</DOC>
	<brief_summary>The purpose of this study is to evaluate if lidocaine-prilocaine (EMLA 5%) cream can reduce pain and discomfort at the time of vaginal pessary removal and insertion. Half of the participants will receive lidocaine-prilocaine (EMLA 5%) cream and the other half will receive a placebo cream.</brief_summary>
	<brief_title>Topical Anesthetic Use In Pessary Management</brief_title>
	<detailed_description>Lidocaine-prilocaine (EMLA 5%) cream has been shown to be effective in reducing pain during minor gynecologic procedures. The primary objective of this trial is to determine if the use of 5% EMLA cream at the time of pessary removal and insertion reduces pain when compared to the use of placebo cream. Participants will be randomized to receive either 10 grams of 5% EMLA cream (4 mL) or 4 mL of placebo cream (aqueous cream BP). Cream will be applied in office at the time of pessary removal and insertion.</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Prilocaine</mesh_term>
	<mesh_term>EMLA</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Women in the Loyola Urogynecology clinic who use a pessary for management of pelvic organ prolapse (POP) or urinary incontinence (UI) Read and speak the English language NonEnglish speaking Allergy or contraindication to topical anesthetic Participation/randomization in the study at a previous visit Currently pregnant or lactating or planning a pregnancy within the next 6 months</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pessary</keyword>
	<keyword>Pain</keyword>
	<keyword>EMLA</keyword>
	<keyword>lidocaine</keyword>
	<keyword>prilocaine</keyword>
</DOC>